AFTON OWEN: Open Payments
NPI 1689254609 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 63 payments from 19 companies in 2025. Trend: 2023 $149 · 2024 $408 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $207 |
| AstraZeneca Pharmaceuticals LP | 13 | $193 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Merck Sharp & Dohme LLC | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $83 |
| PFIZER INC. | 2 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Verona Pharma, Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $30 |
Products named: Kerendia, VRAYLAR, BREZTRI, PREVNAR 20, Fabhalta, QULIPTA, FARXIGA, AIRSUPRA.
Industry payments across OK — which companies pay providers there.
